drugset

drugset / Trial / NCT07606820

Real-World Study of Cligabalin(HSK16149) for the Treatment of Rosacea

NCT07606820 ↗

Enrolling by invitation 60 enrolled The First Affiliated Hospital with Nanjing Medical University

RandomizedParallel-groupOpen-labelOther

Summary

A Real-World Study of Cligabalin(HSK16149) for the Treatment of Rosacea

Timeline

Start: 2025-10-29
Primary completion: 2026-10-30
Completion: 2026-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cligabalin	Unknown	20 mg	Oral

Indications